Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
about
The in vivo evidence for regulated necrosis.The Contribution of Necroptosis in Neurodegenerative Diseases.Necroptosis and Cancer.Necroptosis in neurodegenerative diseases: a potential therapeutic target.FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts.
P2860
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@ast
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@en
type
label
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@ast
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@en
prefLabel
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@ast
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
@en
P2093
P2860
P356
P1476
Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target
@en
P2093
C A Wassif
F D Porter
P2860
P356
10.1038/CDDIS.2016.16
P577
2016-03-17T00:00:00Z